Iroxanadine T27627
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Iroxanadine, a MAPK p38 inhibitor, is used potentially for the treatment of atherosclerosis.
CAS nr:
276690-58-5
Purity:
98%
Molecular Weight:
260,34
SMILES:
C1(C2=CC=CN=C2)=NC(CN3CCCCC3)CON1
Formula:
C14H20N4O
Pathway:
Target:
